MicroRNA‑296‑5p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion

Related Experiment Video

Updated: Mar 1, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Xiaojun Ma1, Baoxiang Zhuang1, Wentao Li1

  • 1Morphological Laboratory, Clinical Medical College, Weifang Medical University, Weifang, Shandong 261053, P.R. China.

Molecular Medicine Reports
|June 7, 2017
PubMed

Insights

MicroRNA-296-5p is downregulated in hepatocellular carcinoma (HCC), inhibiting tumor growth and metastasis. Restoring miR-296-5p levels offers a potential therapeutic strategy for HCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer with poor patient prognosis.
  • MicroRNAs (miRNAs) play a critical role in cancer development, including HCC.
  • Understanding miRNA dysregulation is key to developing novel HCC therapies.

Purpose of the Study:

  • To investigate the expression and function of miR-296-5p in hepatocellular carcinoma.
  • To identify the molecular targets and pathways regulated by miR-296-5p in HCC.

Main Methods:

  • Quantitative real-time PCR to assess miR-296-5p expression in HCC tissues and cell lines.
  • In vitro gain-of-function assays to evaluate the effects of miR-296-5p on HCC cell behavior.
  • Bioinformatic analysis and luciferase reporter assays to identify and validate miR-296-5p targets.

Main Results:

  • miR-296-5p was significantly downregulated in HCC tissues and cell lines.
  • Reduced miR-296-5p expression correlated with advanced tumor stage, size, and metastasis.
  • Overexpression of miR-296-5p suppressed HCC cell proliferation, migration, and invasion.
  • AKT2 was identified as a direct target of miR-296-5p in HCC.

Conclusions:

  • The miR-296-5p/AKT2 axis is crucial in HCC progression.
  • miR-296-5p acts as a tumor suppressor in HCC by targeting AKT2.
  • Targeting the miR-296-5p/AKT2 pathway presents a promising therapeutic strategy for HCC.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K